SEC 13F Intelligence

Clark & Stuart, Inc / ABT

Clark & Stuart, Inc’s Abbott Laboratories Position

Does Clark & Stuart, Inc own Abbott Laboratories (ABT)? Yes — 15.2K shares worth $2M (+1.05% of its 13F portfolio) as of Q1 2026, down from 15.3K shares the prior filed quarter.

Position Value
$2M
Q1 2026
Shares
15.2K
% of Portfolio
+1.05%
Quarters Held
6
currently held

Position History ABT

Reported value by quarter
Q4 ’24: $2MQ4 ’24Q1 ’25: $3MQ1 ’25Q2 ’25: $2MQ2 ’25Q3 ’25: $2MQ3 ’25Q4 ’25: $2MQ4 ’25Q1 ’26: $2MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202615.2K$2M+1.05%
Q4 202515.3K$2M+1.32%
Q3 202515.4K$2M+1.47%
Q2 202515.4K$2M+1.58%
Q1 202519.3K$3M+1.86%
Q4 202419.3K$2M+1.60%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Clark & Stuart, Inc’s full portfolio or all institutional holders of ABT.